Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Cicero Diagnostics
company
About
Cicero Diagnostics is a women’s healthcare diagnostic company.
- 1 - 10
Highlights
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1M
- Industries
- Health Care,Health Diagnostics,Women's
- Founded date
- Jan 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Cicero Diagnostics is a women’s healthcare diagnostic company. It is dedicated to the advancement of clinical assays for understudied women’s diseases primarily in the area of infertility. Its current testing platforms, under the brand ReceptivaDx™ , include several biomarkers highly associated with inflammation on the uterine lining most often diagnosed as endometriosis.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$1M
Cicero Diagnostics has raised a total of
$1M
in funding over 2 rounds. Their latest funding was raised on
Feb 19, 2020 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 19, 2020 | Grant | $1M | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Cicero Diagnostics is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
